initial public offerings (IPOs) trading on American exchanges
Showing posts with label TDOC. Show all posts
Showing posts with label TDOC. Show all posts

Thursday, July 25, 2019

Livongo Health (LVGO) began trading on the Nasdaq on Thur 25 July 2019

Note: Livongo Health acquired by Teladoc (TDOC) for approx. $18.5 billion. (Aug 2020)
The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014.
  • Sector: Healthcare
  • Industry: Medical Devices
  • Full Time Employees: 576
  • Incorporated in 2008
  • HQ in Mountain View, California
  • https://www.livongo.com

Livongo Health opens for trading at $40.51 after pricing IPO at $28




Wednesday, July 1, 2015

Teladoc (TDOC) began trading on the NYSE on 24 March 2015

  • Teladoc raised $158 million, offering 8.3 million shares at 19, above its expected range of 15 to 17. 
  • Headquarters: Purchase, NY;   Founded: 2002
  • Teladoc is the first and largest telehealth provider in the nation. It estimates that the public’s frustration with emergency room visits, physician shortages and long waits for appointments will serve as a platform for long-term growth.
  • JPMorgan and Deutsche Bank Securities were Teladoc’s joint book-running managers for the offering. William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were the co-managers. 




Teladoc connects customers in need of health care to board-certified doctors any time of the day or night, including weekends. The on-demand medical consultation services can be conducted via mobile devices, Internet video or telephone, with a service it calls "telehealth."

Teladoc says it completed about 300,000 telehealth visits in 2014, including patient diagnosis, treatment recommendations and medicinal prescriptions.

Teladoc says it had 8.1 million members in 2014, up 31% from 2013. It reported revenue of $43.5 million in 2014, up 122%, and a net loss of $17 million.

"We are very pleased with the investors' positive reaction to the Teladoc story, our market leadership and the opportunity to revolutionize the health care system," company CEO Jason Gorevic said in a statement via email.

Address

2 Manhattanville Rd Ste 203
PURCHASE, NY 10577-2118
United States

Key stats and ratios

Q4 (Dec '16)2016
Net profit margin-38.13%-60.26%
Operating margin-35.37%-57.75%
EBITD margin--38.49%
Return on average assets-18.54%-27.83%
Return on average equity-24.18%-36.25%
Employees670